Personal information

Emails & domains

Verified email domains

Keywords

alpha-1 antitrypsin deficiency

Countries

United Kingdom

Activities

Collapse all

Employment (1)

University Hospitals Coventry and Warwickshire NHS Trust: Coventry, Coventry, GB

2015-10-06 to present | Medical doctor (Respiratory Medicine)
Employment
Source: Self-asserted source
Beatriz Lara

Education and qualifications (2)

Universitat de Lleida: Lleida, Catalunya, ES

2014-09-26 to 2014-09-26 | PhD (Medicina)
Education
Source: Self-asserted source
Beatriz Lara

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

1990-09-01 to 1996-06-30 | MD (Medicina)
Education
Source: Self-asserted source
Beatriz Lara

Works (6)

Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Effectiveness and Safety of IMU-838, in Combination with oseltamivir, in Adults with Coronavirus-19- a feasibility trial

2024-11-02 | Preprint
DOI: 10.1101/2024.10.31.24316416
Contributors: Kavi Sharma; Lisa Berry; Evangelos Vryonis; Asad Ali; Beatriz Lara; Angela Noufaily; Nick Parsons; Christopher Bradley; Becky Haley; Shivam Joshi et al.
Source: check_circle
Crossref

Long-term effect of α1-antitrypsin augmentation therapy on the decline of FEV1in deficient patients: an analysis of the AIR database

ERJ Open Research
2021-07 | Journal article
DOI: 10.1183/23120541.00194-2021
Contributors: Iris G.M. Schouten; Marise J. Kasteleyn; Roula Tsonaka; Robert Bals; Alice C. Turner; Ilaria Ferrarotti; Angelo G. Corsico; Beatriz Lara; Marc Miravitlles; Robert A. Stockley et al.
Source: check_circle
Crossref

Research priorities in α1-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration

ERJ Open Research
2020-10 | Journal article
DOI: 10.1183/23120541.00523-2020
Contributors: Miriam Barrecheguren; Karen O'Hara; Marion Wilkens; Jeanette Boyd; Ewa Kolda; Beatriz Lara; Joanna Chorostowska-Wynimko; Ilaria Ferrarotti; Jan Chlumský; Christian Clarenbach et al.
Source: check_circle
Crossref

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)

International Journal of Chronic Obstructive Pulmonary Disease
2018-03 | Journal article
DOI: 10.2147/COPD.S155226
Contributors: Cristina Esquinas; Sonia Serreri; Miriam Barrecheguren; Esther Rodríguez; Alexa Nuñez; Francisco Casas-Maldonado; Ignacio Blanco; Pietro Pirina; Beatriz Lara; Marc Miravitlles
Source: check_circle
Crossref

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature

Drug Design, Development and Therapy
2017-07 | Journal article
DOI: 10.2147/DDDT.S105207
Contributors: David Parr; Beatriz Lara
Source: check_circle
Crossref

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide

International Journal of Chronic Obstructive Pulmonary Disease
2017-06 | Journal article
DOI: 10.2147/COPD.S137852
Contributors: Ignacio Blanco; Patricia Bueno; Isidro Diego; Sergio Pérez-Holanda; Beatriz Lara; Francisco Casas-Maldonado; Cristina Esquinas; Marc Miravitlles
Source: check_circle
Crossref
How many people are using ORCID?